Azetidine-substituted pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2
US-12180196-B2 · Dec 31, 2024 · US
Preservative containing compositions
US10632202B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10632202-B2 |
| Application number | US-201715442152-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 24, 2017 |
| Priority date | Mar 4, 2016 |
| Publication date | Apr 28, 2020 |
| Grant date | Apr 28, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to compositions providing improved preservative efficacy. The present invention further relates to polyquaternium compound containing compositions having improved the antifungal activity. In certain embodiments, the present invention relates to ophthalmic compositions comprising a polyquaternium compound, a polyol or combination of polyols, borate compound, and an antimicrobial mixture comprising electrolytes and nutrients.
First claim
Opening claim text (preview).
What is claimed is: 1. A composition, comprising a formulation selected from: INGRED- A B C D IENT % w/w % w/w % w/w % w/w Tetrahydro- About 0.05 About 0.05 About 0.05 — zoline Hydrochloride Polyethylene — About 1.12 About 1.12 About 1.12 Glycol 400 Glycerin About 0.50 About 0.25 About 0.25 About 0.25 Hypromellose — About 0.20 — About 0.20 E3 2910 Hypromellose — — About 0.36 — E4M 2910 Boric Acid About 0.52 About 0.52 About 0.52 About 0.52 Sodium Borate About 0.06 About 0.06 About 0.06 About 0.06 Disodium About 0.027 About 0.027 About 0.027 About 0.027 Phosphate Sodium About About About About Citrate 0.0009 0.0009 0.0009 0.0009 Dihydrate Potassium About 0.18 About 0.18 About 0.18 About 0.18 Chloride Sodium About 0.15 About 0.12 About 0.12 About 0.12 Chloride 50% Aqueous About 0.057 About 0.056 About 0.056 About 0.056 Solution of Sodium Lactate Magnesium About 0.013 About 0.013 About 0.013 About 0.013 Chloride Glucose About 0.004 About 0.004 About 0.004 About 0.004 Glycine About About About About 0.00002 0.00002 0.00002 0.00002 Ascorbic Acid About About About About 0.00001 0.00001 0.00001 0.00001 Poly- About 0.003 About 0.003 About 0.003 About 0.003 quaternium 42 Purified Water QS QS QS QS total 100.00% 100.00% 100.00% 100.00%. 2. A composition, comprising a formulation selected from: A B INGREDIENT % w/w % w/w Tetrahydrozoline Hydrochloride 0.05 0.05 Polyethylene Glycol 400 0.40 — Polysorbate 80 — 1.0
Assignees
Inventors
Classifications
Boron compounds · CPC title
with oxygen as the ring hetero atom · CPC title
containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids · CPC title
Quaternary ammonium compounds · CPC title
Acyclic compounds · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10632202B2 cover?
- The present invention relates to compositions providing improved preservative efficacy. The present invention further relates to polyquaternium compound containing compositions having improved the antifungal activity. In certain embodiments, the present invention relates to ophthalmic compositions comprising a polyquaternium compound, a polyol or combination of polyols, borate compound, and an …
- Who is the assignee on this patent?
- Johnson & Johnson Consumer Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K9/08. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).